The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient ...

Shares of ImmunityBio IBRX surged 17.4% after it announced a recent face-to-face meeting with senior FDA officials to align ...

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it recently held a Type B ...

KIPP Kansas City employees say staff turnover and leadership changes have contributed to issues such as incorrect pay, ...

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

To empower young innovators, ignite creativity, and translate bold ideas into technology-driven, real-world solutions, ...

A prospective phase I/II clinical trial led by QST Hospital reports that carbon-ion radiotherapy achieved five-year local control and disease-free survival rates of 92%, with no grade ≥2 toxicities, ...

Conexis VMS wins 2025 Brandon Hall Group™ HCM Excellence Award for Best Advance in HR and Workforce Management ...

Mairs & Power Growth Fund trailed the S&P 500 in 2025 with a 10.54% return amid AI-driven market concentration. Review the ...

Several students from the Texas Panhandle earned their college degrees and a spot on the President's and Dean's Lists.

Strategic Revenue Insights Inc. - The global Hyaluronic Acid Skin Care Products Market is entering a period of accelerated, data-backed expansion, driven by rising consumer preference for ...